JPMorgan Chase & Co’s ProKidney PROK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $988K | Buy |
1,668,642
+1,615,243
| +3,025% | +$956K | ﹤0.01% | 3734 |
|
|
2025
Q1 | $46.8K | Sell |
53,399
-13,016
| -20% | -$11.4K | ﹤0.01% | 5055 |
|
|
2024
Q4 | $112K | Buy |
66,415
+19,585
| +42% | +$33.1K | ﹤0.01% | 4733 |
|
|
2024
Q3 | $89.9K | Buy |
46,830
+18,472
| +65% | +$35.5K | ﹤0.01% | 4769 |
|
|
2024
Q2 | $69.8K | Buy |
28,358
+7,546
| +36% | +$18.6K | ﹤0.01% | 4775 |
|
|
2024
Q1 | $34.1K | Sell |
20,812
-9,252
| -31% | -$15.2K | ﹤0.01% | 5093 |
|
|
2023
Q4 | $53.5K | Buy |
30,064
+133
| +0.4% | +$237 | ﹤0.01% | 4992 |
|
|
2023
Q3 | $137K | Sell |
29,931
-18,076
| -38% | -$82.8K | ﹤0.01% | 4441 |
|
|
2023
Q2 | $537K | Buy |
48,007
+43,725
| +1,021% | +$489K | ﹤0.01% | 3723 |
|
|
2023
Q1 | $49K | Buy |
4,282
+915
| +27% | +$10.5K | ﹤0.01% | 4901 |
|
|
2022
Q4 | $23K | Buy |
+3,367
| New | +$23K | ﹤0.01% | 4939 |
|
|
2022
Q3 | – | Sell |
-100,000
| Closed | -$995K | – | 5752 |
|
|
2022
Q2 | $995K | Sell |
100,000
-310,356
| -76% | -$3.09M | ﹤0.01% | 3463 |
|
|
2022
Q1 | $4.06M | Buy |
+410,356
| New | +$4.06M | ﹤0.01% | 2705 |
|
|
2021
Q4 | – | Sell |
-150,000
| Closed | -$1.47M | – | 5862 |
|
|
2021
Q3 | $1.47M | Buy |
150,000
+55,300
| +58% | +$542K | ﹤0.01% | 3368 |
|
|
2021
Q2 | $959K | Buy |
+94,700
| New | +$959K | ﹤0.01% | 3665 |
|